Ionis Pharmaceuticals (IONS) Receivables - Other (2009 - 2026)

Ionis Pharmaceuticals' Receivables - Other history runs 18 years deep, the most recent figure standing at $73.7 million for Q1 2026.

• In Q1 2026, Receivables - Other rose 85.57% year-over-year to $73.7 million; the TTM figure through Mar 2026 stood at $73.7 million (up 85.57% YoY), while the FY2025 annual figure was $66.1 million, down 28.34% from the prior year.
• Receivables - Other was $73.7 million for Q1 2026 at Ionis Pharmaceuticals, up from $66.1 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $142.4 million in Q3 2023 to a low of $5.1 million in Q1 2024.
• Historically, Receivables - Other has averaged $43.9 million across 5 years, with a median of $27.3 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Receivables - Other soared 2042.35% in 2023, then sank 87.41% in 2024.
• A 5-year view of Receivables - Other shows it stood at $25.5 million in 2022, then jumped by 282.87% to $97.8 million in 2023, then slipped by 5.72% to $92.2 million in 2024, then dropped by 28.34% to $66.1 million in 2025, then rose by 11.54% to $73.7 million in 2026.
• The last three Receivables - Other figures came in at $73.7 million (Q1 2026), $66.1 million (Q4 2025), and $24.6 million (Q3 2025), per Business Quant data.